BlueRock Therapeutics
Striving to transform the treatment of disease by harnessing the power of cell therapy
478 employees · est. 2016 · Cambridge, United States
Kenai Therapeutics
Pioneering next generation approaches to cure neurological conditions
39 employees · est. 2022 · San Diego, United States
BlueRock Therapeutics is the older company (2016 vs 2022); BlueRock Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | BlueRock Therapeutics | Kenai Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2016 older | 2022 |
| Headquarters | ||
| Headquarters | Cambridge, United States | San Diego, United States |
| Employees | ||
| Employees | 478 larger | 39 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Acquired | Series A |
| Total Funding | ||
| Total Funding | $1.23B | $89.00M |
| Funding Rounds | ||
| Funding Rounds | 2 | 3 |
| Services | ||
| Services | Development of Cell Therapies, Clinical Trial Management, Research and Development | dopamine neuron replacement therapies, gene-modified medicines development, conducting clinical trials targeting neurological disorders |
| Target Customers | ||
| Target Customers | Patients with Degenerative Diseases, Healthcare Providers, Medical Researchers | patients with neurological conditions, medical professionals, investors in biotechnology |
| Taxonomy | ||
| Taxonomy | Cell Therapy, Clinical Stage Biotech, Neurological Diseases, Ophthalmic Diseases, Parkinson’s Disease, Photoreceptor Diseases, Induced Pluripotent Stem Cells (iPSC), Regenerative Medicine, Heart Muscle Regeneration, Myocardial Infarction Treatment, Chronic Heart Failure, Engineered Cell Therapy, Biopharmaceuticals, Stem Cell Therapeutics, Genome Medicine | Neurological Disorders, Cell Therapies, Induced Pluripotent Stem Cells, Neuron Replacement, Therapeutics, Nobel Prize, IPSC Technology, Clinical Development, Surgical Delivery, Global Partnerships |
| Website | ||
| Website | bluerocktx.com | kenaitx.com |
About BlueRock Therapeutics
BlueRock Therapeutics is a cutting-edge, clinical-stage cell therapy company dedicated to reshaping the landscape of disease treatment. Emphasizing the transformative potential of cell therapy, it has constructed a promising pipeline targeting severe neurological and ophthalmic conditions. Key clini...
About Kenai Therapeutics
Kenai Therapeutics, established in 2022, is a biotechnology firm at the forefront of developing innovative solutions to combat neurological conditions. With their slogan, "Pioneering next generation approaches to cure neurological conditions," they focus on advancing off-the-shelf dopamine neuron re...
We will tell you when either one moves
BounceWatch watches BlueRock Therapeutics and Kenai Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at BlueRock Therapeutics and Kenai Therapeutics — by email.
Frequently Asked Questions
Compare BlueRock Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at BlueRock Therapeutics on 9 Jun 2026, and Kenai Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
